This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Shengping Medical Equipment Co., Ltd., Vastpro (Zhejiang) Pharmaceutical Co., Ltd., Zhejiang Boxiao Biopharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hua Bai and a Potentially Scalable Route to Tetrodotoxin
Introduction
Hua Bai is an inventor associated with Shanghai, China. His work includes a patent describing a biological and chemical synthesis method for tetrodotoxin, a compound traditionally obtained through extraction from pufferfish.
Latest Patents
Bai is associated with 1 patent: “Method for Large-Scale Synthesis of Tetrodotoxin.” The invention begins with benzyl acetate, an inexpensive and readily available raw material, and uses biological fermentation to produce an optically pure intermediate, ((5S, 6R)-5, 6-dihydroxycyclohexa-1, 3-dienyl) methyl acetate. A series of chemical conversions then yields tetrodotoxin with a reported purity of at least 95%, without purifying the product. The method is presented as having potential for large-scale production and as an alternative to extraction from pufferfish.
Career Highlights
Bai has been associated with Shanghai Shengping Medical Equipment Co., Ltd. and Vastpro (Zhejiang) Pharmaceutical Co., Ltd. The available information does not specify his roles or dates of employment at these companies.
Collaborations
Bai’s listed coworkers include Guangyin Wang and Xiaoming Li. The available information does not detail their specific contributions to the patent or related work.
Conclusion
Hua Bai’s patent describes a fermentation-based and chemical route to tetrodotoxin that may offer a scalable alternative to pufferfish extraction.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile